Cargando…
Diffusion-weighted magnetic resonance imaging for tumour response assessment: why, when and how?
Diffusion-weighted magnetic resonance imaging (DWI) is increasingly being used to assess tumour response to a variety of anticancer treatments. The technique is quick to perform without the need for administration of exogenous contrast medium, and enables the apparent diffusion coefficient (ADC) of...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
e-Med
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2967137/ https://www.ncbi.nlm.nih.gov/pubmed/20880779 http://dx.doi.org/10.1102/1470-7330.2010.9032 |